281 related articles for article (PubMed ID: 14594809)
1. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
[TBL] [Abstract][Full Text] [Related]
2. Role of Backbone Dynamics in Modulating the Interactions of Disordered Ligands with the TAZ1 Domain of the CREB-Binding Protein.
Berlow RB; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2019 Mar; 58(10):1354-1362. PubMed ID: 30775911
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitive termination of the hypoxic response by a disordered protein switch.
Berlow RB; Dyson HJ; Wright PE
Nature; 2017 Mar; 543(7645):447-451. PubMed ID: 28273070
[TBL] [Abstract][Full Text] [Related]
4. Investigations of the underlying mechanisms of HIF-1α and CITED2 binding to TAZ1.
Chu WT; Chu X; Wang J
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5595-5603. PubMed ID: 32123067
[TBL] [Abstract][Full Text] [Related]
5. Multivalency enables unidirectional switch-like competition between intrinsically disordered proteins.
Berlow RB; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012986
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.
Dames SA; Martinez-Yamout M; De Guzman RN; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5271-6. PubMed ID: 11959977
[TBL] [Abstract][Full Text] [Related]
7. Electrostatic Forces Control the Negative Allosteric Regulation in a Disordered Protein Switch.
Wang Y; Brooks Iii CL
J Phys Chem Lett; 2020 Feb; 11(3):864-868. PubMed ID: 31940206
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
[TBL] [Abstract][Full Text] [Related]
9. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
[TBL] [Abstract][Full Text] [Related]
10. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
Tien ES; Davis JW; Vanden Heuvel JP
J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding of HIF-1α and CITED2 to the TAZ1 domain of CBP from molecular simulations.
Ruiz-Ortiz I; De Sancho D
Phys Chem Chem Phys; 2020 Apr; 22(15):8118-8127. PubMed ID: 32242581
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of allostery in a facilitated dissociation process.
Appling FD; Berlow RB; Stanfield RL; Dyson HJ; Wright PE
Structure; 2021 Dec; 29(12):1327-1338.e5. PubMed ID: 34520739
[TBL] [Abstract][Full Text] [Related]
13. CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.
De Guzman RN; Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2005 Jan; 44(2):490-7. PubMed ID: 15641773
[TBL] [Abstract][Full Text] [Related]
14. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
15. An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization.
Usui-Ouchi A; Aguilar E; Murinello S; Prins M; Gantner ML; Wright PE; Berlow RB; Friedlander M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28297-28306. PubMed ID: 33106407
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.
Kallio PJ; Okamoto K; O'Brien S; Carrero P; Makino Y; Tanaka H; Poellinger L
EMBO J; 1998 Nov; 17(22):6573-86. PubMed ID: 9822602
[TBL] [Abstract][Full Text] [Related]
17. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM
Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100
[TBL] [Abstract][Full Text] [Related]
18. FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2.
Machado-Oliveira G; Guerreiro E; Matias AC; Facucho-Oliveira J; Pacheco-Leyva I; Bragança J
Arch Biochem Biophys; 2015 Jun; 576():61-72. PubMed ID: 25956243
[TBL] [Abstract][Full Text] [Related]
19. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
Shin DH; Li SH; Chun YS; Huang LE; Kim MS; Park JW
Oncogene; 2008 Mar; 27(13):1939-44. PubMed ID: 17906695
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
